This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
FMC (FMC) Reliance on International Sales: What Investors Need to Know
by Zacks Equity Research
Examine the evolution of FMC's (FMC) overseas revenue trends and their effects on Wall Street's forecasts and the stock's prospects.
FMC vs. CTVA: Which Stock Is the Better Value Option?
by Zacks Equity Research
FMC vs. CTVA: Which Stock Is the Better Value Option?
FMC (FMC) Reports Q2 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
Although the revenue and EPS for FMC (FMC) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
FMC's Earnings Surpass Estimates in Q2 on Higher Volumes
by Zacks Equity Research
FMC posts better-than-expected Q2 results as higher volumes offset price declines.
FMC (FMC) Q2 Earnings and Revenues Beat Estimates
by Zacks Equity Research
FMC (FMC) delivered earnings and revenue surprises of +16.95% and +8.82%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
These 2 Consumer Staples Stocks Could Beat Earnings: Why They Should Be on Your Radar
by Zacks Equity Research
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
FMC (FMC) Expected to Beat Earnings Estimates: Should You Buy?
by Zacks Equity Research
FMC (FMC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
FMC or CTVA: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
FMC vs. CTVA: Which Stock Is the Better Value Option?
Will FMC (FMC) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
FMC (FMC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
FMC's Tremisia Fungicide Debuts in EMEA Region After Approvals
by Zacks Equity Research
FMC launches Tremisia fungicide in Ukraine, bringing fluindapyr tech to EMEA growers battling major crop diseases.
How to Boost Your Portfolio with Top Consumer Staples Stocks Set to Beat Earnings
by Zacks Equity Research
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Why Is ADM (ADM) Down 1.3% Since Last Earnings Report?
by Zacks Equity Research
ADM (ADM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
FMC and Corteva Partner to Expand Access to Fluindapyr Fungicide
by Zacks Equity Research
FMC teams up with Corteva to expand fluindapyr fungicide access, targeting key U.S. corn and soybean markets.
Why Is FMC (FMC) Up 2.3% Since Last Earnings Report?
by Zacks Equity Research
FMC (FMC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Why FMC (FMC) International Revenue Trends Deserve Your Attention
by Zacks Equity Research
Examine FMC's (FMC) international revenue patterns and their implications on Wall Street's forecasts and the prospective trajectory of the stock.
FMC Corp's Earnings and Revenues Surpass Estimates in Q1
by Zacks Equity Research
Lower prices, mostly due to price adjustments in certain contracts, hurt FMC's Q1 sales.
FMC (FMC) Tops Q1 Earnings and Revenue Estimates
by Zacks Equity Research
FMC (FMC) delivered earnings and revenue surprises of 125% and 1.59%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
FMC to Report Q1 Earnings: What's in the Cards for the Stock?
by Zacks Equity Research
FMC's cost actions and new product launches are expected to have contributed to its performance amid headwinds from de-stocking in Q1.
How to Boost Your Portfolio with Top Consumer Staples Stocks Set to Beat Earnings
by Zacks Equity Research
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
How to Find Strong Consumer Staples Stocks Slated for Positive Earnings Surprises
by Zacks Equity Research
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
FMC (FMC) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
by Zacks Equity Research
FMC (FMC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
FMC Secures Regulatory Approval for Keenali Herbicide in Peru
by Zacks Equity Research
FMC's Keenali herbicide is expected to be commercially available in Peru in August after receiving regulatory approvals.
FMC Secures First Product Registration in Brazil for Sofera Fall
by Zacks Equity Research
FMC gets Sofera Fall registered in Brazil to reach growers with its innovative pest control system against the fall armyworm.
Will FMC (FMC) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
FMC (FMC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Want Better Returns? Don?t Ignore These 2 Consumer Staples Stocks Set to Beat Earnings
by Zacks Equity Research
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.